AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
Oncology Grand Rounds, Prof. John Haanen | August 21st
Events
EPFL Latsis Symposium 2026 | October 29-30
Latest publications
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.
Cole AR, Buj R, Uboveja A, (…), Hempel N, Snyder NW, Aird KM
Nature aging – 2026 Jul 30
Who gets told what is impossible?
Joyce JA
Nature reviews. Cancer – 2026 Jul 27
Driving tumor-associated macrophages to a CXCL9(Hi)/SPP1(Low) phenotype eliminates pancreatic cancer.
Nguyen YTM, Pfefferlé M, Oh J, (…), Liss AS, Pittet MJ, Weissleder R
Cell reports. Medicine – 2026 Jul 23
Beyond neutralization: A comprehensive framework for evaluating humoral immunity induced by a live-attenuated tetravalent dengue vaccine.
Gottardo R, Dean H, Nascimento EJM, Tricou V, Sharma M
Vaccine – 2026 Jul 21
[(18)F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice.
Santo G, Pozzessere C, Michielin O, (…), Cascini GL, Prior JO, Cicone F
European journal of nuclear medicine and molecular imaging – 2026 Jul 17